ImageneBio (IMA) Operating Margin (2020 - 2024)
Historic Operating Margin for ImageneBio (IMA) over the last 5 years, with Q3 2024 value amounting to 58.17%.
- ImageneBio's Operating Margin rose 15876500.0% to 58.17% in Q3 2024 from the same period last year, while for Dec 2024 it was 1834.29%, marking a year-over-year decrease of 10110600.0%. This contributed to the annual value of 823.33% for FY2023, which is 3693400.0% down from last year.
- As of Q3 2024, ImageneBio's Operating Margin stood at 58.17%, which was up 15876500.0% from 3324.43% recorded in Q4 2023.
- In the past 5 years, ImageneBio's Operating Margin registered a high of 13.81% during Q4 2021, and its lowest value of 40081.54% during Q4 2020.
- For the 5-year period, ImageneBio's Operating Margin averaged around 3205.03%, with its median value being 292.02% (2023).
- In the last 5 years, ImageneBio's Operating Margin skyrocketed by 400953500bps in 2021 and then tumbled by -51270700bps in 2022.
- Over the past 5 years, ImageneBio's Operating Margin (Quarter) stood at 40081.54% in 2020, then soared by 100bps to 13.81% in 2021, then plummeted by -2108bps to 277.32% in 2022, then plummeted by -1099bps to 3324.43% in 2023, then soared by 98bps to 58.17% in 2024.
- Its last three reported values are 58.17% in Q3 2024, 3324.43% for Q4 2023, and 1645.82% during Q3 2023.